Value
5.2/10data confidence 100%| Component | Sub-score |
|---|---|
| P/E | 4.5 |
| P/S | 9.5 |
| EV/EBITDA | 0.0 |
| Fwd P/E | 7.1 |
| PEG | 5.8 |
| Analyst target | 4.0 |
- ▸Forward P/E: 17.7x
- ▸PEG: 1.30
PACS · Why this verdict
Why PACS Group (PACS) is rated SELL
Updated
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
VerdictSELL
Overall score5.5/10
ConfidenceMEDIUM
MacroNEUTRAL
Thesis pillars
| Pillar | Expectation | Trend |
|---|---|---|
PACS Group converts 124% of net income into free cash flow and generates a return on equity of 27%, indicating strong underlying cash generation relative to reported earnings and efficient use of equity capital. Quality breakdown | Free cash flow conversion remains above 80% of net income and return on equity stays above 20% for at least 3 of the next 4 reporting periods. | →Stable |
| CounterHigh free cash flow conversion in healthcare facilities often reflects deferred capital expenditure on physical plant; if maintenance investment is normalized, conversion ratios may decline sharply. | ||
The growth score shows strong earnings growth components at the maximum level, supporting the bull case for a strong growth profile in the skilled nursing and post-acute care market. Bull case | Revenue growth remains above 10% year-over-year for at least 3 of the next 4 quarters. | →Stable |
| CounterPost-acute care operators face reimbursement rate risk from Medicare and Medicaid, which set pricing; a policy change or rate cut could stall growth regardless of operational quality. | ||
A debt-to-equity ratio of 3.4 applies a leverage penalty to the score and limits the financial flexibility to invest in capacity expansion or withstand a revenue shortfall without covenant risk. Bear case | Debt-to-equity declines below 2.5 within 12 months as free cash flow is applied to debt reduction. | →Stable |
| CounterHealthcare facilities regularly operate with leverage ratios above 3x due to real estate-intensive business models; the debt load may be structurally appropriate and not a constraint on growth. | ||
The two most recent quarters both missed earnings estimates — negative 3.8% and negative 5.0% respectively — indicating a potential pattern of elevated guidance-setting or operating cost pressure that is reducing execution reliability. Earnings | The company beats consensus earnings estimates in at least 2 of the next 4 quarters, recovering from the consecutive miss pattern. | →Stable |
| CounterThe two quarters before the misses both produced substantial beats of 57% and 26%, suggesting the earnings trajectory remains strong and the misses may reflect a one-time reset period. | ||
PACS Group converts 124% of net income into free cash flow and generates a return on equity of 27%, indicating strong underlying cash generation relative to reported earnings and efficient use of equity capital.
→StableQuality breakdown
- Expectation
- Free cash flow conversion remains above 80% of net income and return on equity stays above 20% for at least 3 of the next 4 reporting periods.
CounterHigh free cash flow conversion in healthcare facilities often reflects deferred capital expenditure on physical plant; if maintenance investment is normalized, conversion ratios may decline sharply.
The growth score shows strong earnings growth components at the maximum level, supporting the bull case for a strong growth profile in the skilled nursing and post-acute care market.
→StableBull case
- Expectation
- Revenue growth remains above 10% year-over-year for at least 3 of the next 4 quarters.
CounterPost-acute care operators face reimbursement rate risk from Medicare and Medicaid, which set pricing; a policy change or rate cut could stall growth regardless of operational quality.
A debt-to-equity ratio of 3.4 applies a leverage penalty to the score and limits the financial flexibility to invest in capacity expansion or withstand a revenue shortfall without covenant risk.
→StableBear case
- Expectation
- Debt-to-equity declines below 2.5 within 12 months as free cash flow is applied to debt reduction.
CounterHealthcare facilities regularly operate with leverage ratios above 3x due to real estate-intensive business models; the debt load may be structurally appropriate and not a constraint on growth.
The two most recent quarters both missed earnings estimates — negative 3.8% and negative 5.0% respectively — indicating a potential pattern of elevated guidance-setting or operating cost pressure that is reducing execution reliability.
→StableEarnings
- Expectation
- The company beats consensus earnings estimates in at least 2 of the next 4 quarters, recovering from the consecutive miss pattern.
CounterThe two quarters before the misses both produced substantial beats of 57% and 26%, suggesting the earnings trajectory remains strong and the misses may reflect a one-time reset period.
TrendMatrix Research · core thesis
Engine thesis — one sentence
PACS Group delivers excellent cash conversion of 124% free cash flow relative to net income and a return on equity of 27%, with 18% analyst upside, but carries high leverage at debt-to-equity of 3.4 and two consecutive earnings misses that challenge the growth thesis heading into the next earnings cycle.
Falsifiable statement — pillar-level invalidators below. Engine-derived; not personalized advice.
Per-dimension breakdown
Quality
4.8/10data confidence 100%| Component | Sub-score |
|---|---|
| ROE | 9.0 |
| ROA | 2.8 |
| Gross margin | 0.0 |
| Op margin | 3.4 |
| Net margin | 2.2 |
| Current ratio | 4.0 |
| FCF quality | 9.1 |
| Moat | 6.0 |
| Piotroski F | 6.7 |
- ▸Excellent ROE: 27%
- ▸Excellent cash conversion: 124% FCF/NI
Growth
7.7/10data confidence 67%| Component | Sub-score |
|---|---|
| Rev growth | 5.3 |
| EPS growth | 10.0 |
Momentum
7.4/10data confidence 100%| Component | Sub-score |
|---|---|
| RSI | 4.0 |
| MACD | 10.0 |
| OBV | 10.0 |
| MA position | 9.0 |
| Volume | 3.9 |
- ▸Overbought (RSI 79)
- ▸Volume accumulation (rising OBV)
- ▸Above 200-day MA
Sentiment
7.3/10data confidence 100%| Component | Sub-score |
|---|---|
| LLM sentiment | 7.5 |
| Analyst rating | 7.6 |
| Price target | 6.7 |
- ▸LLM news sentiment: +0.50 (n=2)
- ▸Light analyst coverage (6.0) — signal dampened
Insider
3.3/10data confidence 75%| Component | Sub-score |
|---|---|
| materiality | 3.0 |
| insider conviction | 2.0 |
| holder change | 5.0 |
- ▸Notable insider selling — $13,948,087 (0.198% of mkt cap)
Peer rank
4.1/10data confidence 80%| Component | Sub-score |
|---|---|
| value rank | 3.0 |
| quality rank | 6.7 |
| growth rank | 6.6 |
- ▸Superior ROE vs peers
Technical
3.4/10data confidence 100%| Component | Sub-score |
|---|---|
| bollinger | 0.0 |
| support resistance | 0.6 |
| 52w position | 9.7 |
Risk (lower is worse)
3.9/10data confidence 100%| Component | Sub-score |
|---|---|
| short interest | 5.4 |
| days to cover | 5.2 |
| volatility | 0.5 |
| put call | 10.0 |
| implied vol | 0.8 |
| debt equity | 1.6 |
- ▸High IV: 75%
- ▸Concentration risks: 3 MED (10-K Item 1A)
Catalyst
5.9/10data confidence 100%| Component | Sub-score |
|---|---|
| erm | 5.0 |
| earnings history | 3.3 |
| earnings timing | 5.0 |
| surprise avg | 10.0 |
| news activity | 6.0 |
- ▸Earnings concerns: 2B/2M
How the verdict was assembled
Engine trigger
Multiple concerning factors. Consider reducing position.
Engine technical detail
verdict_path:
L4:PATH_F_SELLPassed (5)
- MOMENTUM:7.4>=5.5
- INSIDER:OK
- EARNINGS_PROXIMITY:38d clear
- SEMI_CYCLE_PEAK:CLEAR
- MATERIALS_CYCLE_PEAK:CLEAR
Failed (1)
- ASYMMETRY:-0.2=NEGATIVE
Warning (1)
- 8K_CSUITE_CHANGE:5.02 (officer departure/appointment)
Reward-to-Risk
-0.19
Upside
-2.9%
Downside
15.0%
Sizing output
AVOID
Setup— — No clear chart pattern; technical signals are mixed
EdgeNo clear edge — No clear edge identified
SuitabilityModerate — Balanced profile
Investment implication
The F-path SELL output reflects an overall score of 4.0 below the 5.6 soft trigger — multiple weakening dimensions accumulated rather than a single hard-floor breach. The strongest dimension ( Growth at 7.7) was not enough to lift the adjusted overall above the threshold. Co-occurring failed gates ( ASYMMETRY:-0.2=NEGATIVE) reinforce the read. Current asymmetry R:R is -0.19 — supplementary context, not the trigger for this path.
The strongest dimensions are Growth at 7.7, Momentum at 7.4, and Sentiment at 7.3; the weakest are Insider at 3.3, Technical at 3.4, and Risk (lower is worse) at 3.9. The V9 engine flagged 1 failed gate with 1 warning, producing an asymmetric reward-to-risk of -0.19 and an engine sizing output of AVOID.
What would invalidate the thesis
Falsifying conditions — when triggered, the corresponding pillar's thesis is invalidated.
- P1Strong Fcf Conversion And Roe
Trip ifFree cash flow conversion falls below 50% of net income for 2 consecutive quarters.
- P2Strong Revenue Growth Profile
Trip ifRevenue growth falls below 5% year-over-year for 2 consecutive quarters.
- P3High Leverage Financial Risk
Trip ifDebt-to-equity ratio rises above 4.5 in any reporting period.
- P4Consecutive Earnings Miss Pattern
Trip ifEPS surprise falls below 0% in at least 3 of the next 4 quarters.